APO Research
Talk to an analyst

APO RESEARCH · REPORT

Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2)

Diamantane (CAS 2292-79-7) is a member of the diamondoid family of cage hydrocarbons. With the formula C₁₄H₂₀ and a molecular weight of 188.31 g/mol, it can be viewed as a tricyclic framework constructed from three fused cyclohexane units.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Diamantane (CAS 2292-79-7) is a member of the diamondoid family of cage hydrocarbons. With the formula C₁₄H₂₀ and a molecular weight of 188.31 g/mol, it can be viewed as a tricyclic framework constructed from three fused cyclohexane units. The lattice is an all-sp³, rigid three-dimensional network whose local connectivity echoes that of diamond, conferring exceptional chemical inertness, thermal robustness, and pronounced hydrophobicity. In structural hierarchy, diamantane is the higher homologue of adamantane, preserving the same symmetry logic while increasing framework complexity.

Adamantane (C₁₀H₁₆) is a colorless crystalline solid with a camphor-like odor and is the prototypical diamondoid. Its defining feature is a strain-free, highly symmetrical tricyclic cage of saturated, tetrahedral carbons that restricts internal bond rotation relative to ordinary acyclic or monocyclic hydrocarbons. Adamantane occurs naturally in certain crude oils and is also readily accessible synthetically, making it a durable scaffold for structure–property studies and a useful building block in materials and molecular design.

Synthetically, adamantane can be produced via the thermal, catalyst-assisted rearrangement of dicyclopentadiene (C₁₀H₁₆ → C₁₀H₁₆, Δ, catalyst), a classic cage-forming transformation that delivers a low-strain, high-symmetry framework from readily available feedstock. This blueprint underpins routes to higher diamondoids such as diamantane by extending the logic of cage construction from simpler polycyclic precursors.

According to APO Research’s survey and statistical analysis, the global diamantane market was valued at US$442.21 thousand in 2023 and is projected to reach US$697.62 thousand by 2030, implying a 2024–2030 CAGR of 6.83%. The global adamantane market was valued at US$184.47 million in 2023 and is expected to reach US$262.53 million by 2030 (CAGR 4.97%). By production value, North America’s adamantane market rises from US$51.84 million (2023) to US$72.62 million (2030; 4.75%), while diamantane increases from US$217.62 thousand to US$354.61 thousand (7.49%). Europe’s adamantane advances from US$28.91 million to US$39.80 million (4.44%) and diamantane from US$51.38 thousand to US$76.60 thousand (5.27%). China’s adamantane expands from US$44.45 million to US$71.04 million (6.66%) and diamantane from US$70.22 thousand to US$114.88 thousand (7.51%). Japan’s adamantane grows from US$40.73 million to US$55.47 million (4.28%) and diamantane from US$99.85 thousand to US$147.20 thousand (5.79%). Overall, adamantane retains the larger revenue base with steady growth, while diamantane—though smaller in absolute terms—exhibits a faster compound growth trajectory over 2024–2030.

Composition, supplied form and processing history determine the usable material. Evaluate the property required by the actual application with the specified test method; a chemistry name alone does not define a finished grade.

What turns activity into demand

Qualified formulation or component output creates material purchases through loading, process yield and the supplied mass basis. Raw material, formulated blend and finished-part revenues describe separate transaction stages.

The commercial boundary

For Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2), distinguish the supplied product from its inputs and the complete application. Report types and applications may overlap; retain the selected edition's product definition, geography, period, unit and transaction basis when comparing estimates.

Which conditions determine usable diamantane (cas 2292-79-7) and adamantane (cas 281-23-2) performance?

Diamantane (CAS 2292-79-7) is a member of the diamondoid family of cage hydrocarbons. With the formula C₁₄H₂₀ and a molecular weight of 188.31 g/mol, it can be viewed as a tricyclic framework constructed from three fused cyclohexane units. Match formulation and impurity limits to the converting process, then verify the property after processing or curing. Compare like-for-like dry or as-supplied quantities; a finished component and its raw material represent different transaction stages.

Selected research

Market Analysis & Forecast

Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Analysis and Forecast 2026-2032

21 December 2025211 pages

Choose your research edition.

Industry ResearchDiamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

Diamantane (CAS 2292-79-7) is a member of the diamondoid family of cage hydrocarbons. With the formula C₁₄H₂₀ and a molecular weight of 188.31 g/mol, it can be viewed as a tricyclic framework constructed from three fused cyclohexane units. The lattice is an all-sp³, rigid three-dimensional network whose local connectivity echoes that of diamond, conferring exceptional chemical inertness, thermal robustness, and pronounced hydrophobicity. In structural hierarchy, diamantane is the higher homologue of adamantane, preserving the same symmetry logic while increasing framework complexity.

Adamantane (C₁₀H₁₆) is a colorless crystalline solid with a camphor-like odor and is the prototypical diamondoid. Its defining feature is a strain-free, highly symmetrical tricyclic cage of saturated, tetrahedral carbons that restricts internal bond rotation relative to ordinary acyclic or monocyclic hydrocarbons. Adamantane occurs naturally in certain crude oils and is also readily accessible synthetically, making it a durable scaffold for structure–property studies and a useful building block in materials and molecular design.

Synthetically, adamantane can be produced via the thermal, catalyst-assisted rearrangement of dicyclopentadiene (C₁₀H₁₆ → C₁₀H₁₆, Δ, catalyst), a classic cage-forming transformation that delivers a low-strain, high-symmetry framework from readily available feedstock. This blueprint underpins routes to higher diamondoids such as diamantane by extending the logic of cage construction from simpler polycyclic precursors.

Read the full market overview

According to APO Research’s survey and statistical analysis, the global diamantane market was valued at US$442.21 thousand in 2023 and is projected to reach US$697.62 thousand by 2030, implying a 2024–2030 CAGR of 6.83%. The global adamantane market was valued at US$184.47 million in 2023 and is expected to reach US$262.53 million by 2030 (CAGR 4.97%). By production value, North America’s adamantane market rises from US$51.84 million (2023) to US$72.62 million (2030; 4.75%), while diamantane increases from US$217.62 thousand to US$354.61 thousand (7.49%). Europe’s adamantane advances from US$28.91 million to US$39.80 million (4.44%) and diamantane from US$51.38 thousand to US$76.60 thousand (5.27%). China’s adamantane expands from US$44.45 million to US$71.04 million (6.66%) and diamantane from US$70.22 thousand to US$114.88 thousand (7.51%). Japan’s adamantane grows from US$40.73 million to US$55.47 million (4.28%) and diamantane from US$99.85 thousand to US$147.20 thousand (5.79%). Overall, adamantane retains the larger revenue base with steady growth, while diamantane—though smaller in absolute terms—exhibits a faster compound growth trajectory over 2024–2030.

The global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2)'s global sales reached XX (g) with a value of US$ XX Million, marking an change of XX% compared to the previous year. This performance has positioned TCI America as the global sales leader, a title it has maintained for several consecutive years. Notably, TCI America's performance in primary markets is also remarkable. In the Chinese market, sales were XX (g), a change of XX% from the previous year. In Europe, sales were XX (g), showing a year-on-year of XX%. In the US, sales were XX (g), a year-on-year change of XX%.

The major global manufacturers in the Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) market include TCI America, City Chemical, Combi Blocks, Santa Cruz Biotechnology, abcr GmbH, BOC Sciences, Aceschem Inc, A2B Chem and Amadis Chemical, etc. In 2025, the top three vendors accounted for approximately % of the revenue.

In terms of production side, this report researches the Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) production, growth rate, market share by manufacturers and by region (region level and country level), from 2021 to 2026, and forecast to 2032.

In terms of consumption side, this report focuses on the sales of Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) by region (region level and country level), by Company, by Type and by Application. from 2021 to 2026 and forecast to 2032.

This report presents an overview of global market for Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2), capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2), also provides the consumption of main regions and countries. Of the upcoming market potential for Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) sales, projected growth trends, production technology, application and end-user industry.

Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Segment by Company

TCI America

City Chemical

Combi Blocks

Santa Cruz Biotechnology

abcr GmbH

BOC Sciences

Aceschem Inc

A2B Chem

Amadis Chemical

Chiralen Pharmaceutical

Starshine Chemical

Ambinter (Greenpharma)

AstaTech

Shanghai Maikelin Biochemical Technology

Aladdin

Chiron

Sigma-Aldrich

Thermo Scientific

Matrix Scientific

AbMole Bioscience

Smolecule

Biosynth

Alfa Chemistry

ChemScence

Fujifilm

Sichuan Zhongbang New Materials

Minxiang Pharmaceutical

Meryer (Shanghai) Chemical Technology

J&K Scientific

Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Segment by Type

Purity: ≥98.0% (GC)

Purity: ＜98.0% (GC)

Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Segment by Application

Chemical Reagent

Fine Chemicals

Pharmaceutical Intermediate

Material Intermediate

Medical

Scientific Research

Medical

Scientific Research

Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 4: Sales (consumption), revenue of Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 5: Detailed analysis of Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) sales, revenue, price, gross margin, and recent development, etc.

Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 11: China by type, by application, sales, and revenue for each segment.

Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.

Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 15: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Purity: ≥98.0% (GC) Major Manufacturers Table 3. Purity: ＜98.0% (GC) Major Manufacturers Table 4. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Chemical Reagent Major Manufacturers Table 6. Fine Chemicals Major Manufacturers Table 7. Pharmaceutical Intermediate Major Manufacturers Table 8. Material Intermediate Major Manufacturers Table 9. Medical Major Manufacturers Table 10. Scientific Research Major Manufacturers Table 11. Medical Major Manufacturers Table 12. Scientific Research Major Manufacturers Table 13. Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Industry Trends Table 14. Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Industry Drivers Table 15. Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Industry Opportunities and Challenges Table 16. Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Industry Restraints Table 17. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Production Growth Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (g) Table 18. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Production by Region (2021-2026) & (g) Table 19. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Production by Region (2027-2032) & (g) Table 20. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Production Market Share by Region (2021-2026) Table 21. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Production Market Share by Region (2027-2032) Table 22. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 23. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Region (2021-2026) & (US$ Million) Table 24. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Region (2027-2032) & (US$ Million) Table 25. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue Market Share by Region (2021-2026) Table 26. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue Market Share by Region (2027-2032) Table 27. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (g) Table 28. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Region (2021-2026) & (g) Table 29. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Region (2027-2032) & (g) Table 30. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share by Region (2021-2026) Table 31. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share by Region (2027-2032) Table 32. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 33. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue Market Share by Manufacturers (2021-2026) Table 34. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Manufacturers (US$ Million) & (2021-2026) Table 35. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share by Manufacturers (2021-2026) Table 36. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Price (USD/g) of Manufacturers (2021-2026) Table 37. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 38. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Key Manufacturers Manufacturing Sites & Headquarters Table 39. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Manufacturers, Product Type & Application Table 40. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Manufacturers Commercialization Time Table 41. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 42. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 43. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Type (2021-2026) & (US$ Million) Table 44. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Type (2027-2032) & (US$ Million) Table 45. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue Market Share by Type (2021-2026) Table 46. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue Market Share by Type (2027-2032) Table 47. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Type (2021-2026) & (g) Table 48. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Type (2027-2032) & (g) Table 49. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share by Type (2021-2026) Table 50. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share by Type (2027-2032) Table 51. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Price by Type (2021-2026) & (USD/g) Table 52. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Price by Type (2027-2032) & (USD/g) Table 53. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Application (2021-2026) & (US$ Million) Table 54. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Application (2027-2032) & (US$ Million) Table 55. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue Market Share by Application (2021-2026) Table 56. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue Market Share by Application (2027-2032) Table 57. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Application (2021-2026) & (g) Table 58. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Application (2027-2032) & (g) Table 59. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share by Application (2021-2026) Table 60. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share by Application (2027-2032) Table 61. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Price by Application (2021-2026) & (USD/g) Table 62. Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Price by Application (2027-2032) & (USD/g) Table 63. TCI America Company Information Table 64. TCI America Business Overview Table 65. TCI America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 66. TCI America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 67. TCI America Recent Development Table 68. City Chemical Company Information Table 69. City Chemical Business Overview Table 70. City Chemical Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 71. City Chemical Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 72. City Chemical Recent Development Table 73. Combi Blocks Company Information Table 74. Combi Blocks Business Overview Table 75. Combi Blocks Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 76. Combi Blocks Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 77. Combi Blocks Recent Development Table 78. Santa Cruz Biotechnology Company Information Table 79. Santa Cruz Biotechnology Business Overview Table 80. Santa Cruz Biotechnology Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 81. Santa Cruz Biotechnology Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 82. Santa Cruz Biotechnology Recent Development Table 83. abcr GmbH Company Information Table 84. abcr GmbH Business Overview Table 85. abcr GmbH Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 86. abcr GmbH Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 87. abcr GmbH Recent Development Table 88. BOC Sciences Company Information Table 89. BOC Sciences Business Overview Table 90. BOC Sciences Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 91. BOC Sciences Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 92. BOC Sciences Recent Development Table 93. Aceschem Inc Company Information Table 94. Aceschem Inc Business Overview Table 95. Aceschem Inc Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 96. Aceschem Inc Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 97. Aceschem Inc Recent Development Table 98. A2B Chem Company Information Table 99. A2B Chem Business Overview Table 100. A2B Chem Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 101. A2B Chem Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 102. A2B Chem Recent Development Table 103. Amadis Chemical Company Information Table 104. Amadis Chemical Business Overview Table 105. Amadis Chemical Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 106. Amadis Chemical Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 107. Amadis Chemical Recent Development Table 108. Chiralen Pharmaceutical Company Information Table 109. Chiralen Pharmaceutical Business Overview Table 110. Chiralen Pharmaceutical Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 111. Chiralen Pharmaceutical Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 112. Chiralen Pharmaceutical Recent Development Table 113. Starshine Chemical Company Information Table 114. Starshine Chemical Business Overview Table 115. Starshine Chemical Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 116. Starshine Chemical Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 117. Starshine Chemical Recent Development Table 118. Ambinter (Greenpharma) Company Information Table 119. Ambinter (Greenpharma) Business Overview Table 120. Ambinter (Greenpharma) Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 121. Ambinter (Greenpharma) Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 122. Ambinter (Greenpharma) Recent Development Table 123. AstaTech Company Information Table 124. AstaTech Business Overview Table 125. AstaTech Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 126. AstaTech Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 127. AstaTech Recent Development Table 128. Shanghai Maikelin Biochemical Technology Company Information Table 129. Shanghai Maikelin Biochemical Technology Business Overview Table 130. Shanghai Maikelin Biochemical Technology Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 131. Shanghai Maikelin Biochemical Technology Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 132. Shanghai Maikelin Biochemical Technology Recent Development Table 133. Aladdin Company Information Table 134. Aladdin Business Overview Table 135. Aladdin Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 136. Aladdin Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 137. Aladdin Recent Development Table 138. Chiron Company Information Table 139. Chiron Business Overview Table 140. Chiron Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 141. Chiron Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 142. Chiron Recent Development Table 143. Sigma-Aldrich Company Information Table 144. Sigma-Aldrich Business Overview Table 145. Sigma-Aldrich Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 146. Sigma-Aldrich Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 147. Sigma-Aldrich Recent Development Table 148. Thermo Scientific Company Information Table 149. Thermo Scientific Business Overview Table 150. Thermo Scientific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 151. Thermo Scientific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 152. Thermo Scientific Recent Development Table 153. Matrix Scientific Company Information Table 154. Matrix Scientific Business Overview Table 155. Matrix Scientific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 156. Matrix Scientific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 157. Matrix Scientific Recent Development Table 158. AbMole Bioscience Company Information Table 159. AbMole Bioscience Business Overview Table 160. AbMole Bioscience Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 161. AbMole Bioscience Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 162. AbMole Bioscience Recent Development Table 163. Smolecule Company Information Table 164. Smolecule Business Overview Table 165. Smolecule Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 166. Smolecule Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 167. Smolecule Recent Development Table 168. Biosynth Company Information Table 169. Biosynth Business Overview Table 170. Biosynth Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 171. Biosynth Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 172. Biosynth Recent Development Table 173. Alfa Chemistry Company Information Table 174. Alfa Chemistry Business Overview Table 175. Alfa Chemistry Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 176. Alfa Chemistry Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 177. Alfa Chemistry Recent Development Table 178. ChemScence Company Information Table 179. ChemScence Business Overview Table 180. ChemScence Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 181. ChemScence Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 182. ChemScence Recent Development Table 183. Fujifilm Company Information Table 184. Fujifilm Business Overview Table 185. Fujifilm Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 186. Fujifilm Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 187. Fujifilm Recent Development Table 188. Sichuan Zhongbang New Materials Company Information Table 189. Sichuan Zhongbang New Materials Business Overview Table 190. Sichuan Zhongbang New Materials Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 191. Sichuan Zhongbang New Materials Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 192. Sichuan Zhongbang New Materials Recent Development Table 193. Minxiang Pharmaceutical Company Information Table 194. Minxiang Pharmaceutical Business Overview Table 195. Minxiang Pharmaceutical Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 196. Minxiang Pharmaceutical Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 197. Minxiang Pharmaceutical Recent Development Table 198. Meryer (Shanghai) Chemical Technology Company Information Table 199. Meryer (Shanghai) Chemical Technology Business Overview Table 200. Meryer (Shanghai) Chemical Technology Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 201. Meryer (Shanghai) Chemical Technology Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 202. Meryer (Shanghai) Chemical Technology Recent Development Table 203. J&K Scientific Company Information Table 204. J&K Scientific Business Overview Table 205. J&K Scientific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 206. J&K Scientific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio Table 207. J&K Scientific Recent Development Table 208. North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Type (2021-2026) & (US$ Million) Table 209. North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Type (2027-2032) & (US$ Million) Table 210. North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Type (2021-2026) & (g) Table 211. North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Type (2027-2032) & (g) Table 212. North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Price by Type (2021-2026) & (USD/g) Table 213. North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Price by Type (2027-2032) & (USD/g) Table 214. North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Application (2021-2026) & (US$ Million) Table 215. North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Application (2027-2032) & (US$ Million) Table 216. North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Application (2021-2026) & (g) Table 217. North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Application (2027-2032) & (g) Table 218. North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Price by Application (2021-2026) & (USD/g) Table 219. North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Price by Application (2027-2032) & (USD/g) Table 220. North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 221. North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 222. North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 223. North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Country (2021 VS 2025 VS 2032) & (g) Table 224. North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Country (2021-2026) & (g) Table 225. North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Country (2027-2032) & (g) Table 226. North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Price by Country (2021-2026) & (USD/g) Table 227. North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Price by Country (2027-2032) & (USD/g) Table 228. United States Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue (2021-2032) & (US$ Million) Table 229. Canada Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue (2021-2032) & (US$ Million) Table 230. Mexico Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue (2021-2032) & (US$ Million) Table 231. Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Type (2021-2026) & (US$ Million) Table 232. Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Type (2027-2032) & (US$ Million) Table 233. Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Type (2021-2026) & (g) Table 234. Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Type (2027-2032) & (g) Table 235. Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Price by Type (2021-2026) & (USD/g) Table 236. Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Price by Type (2027-2032) & (USD/g) Table 237. Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Application (2021-2026) & (US$ Million) Table 238. Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Application (2027-2032) & (US$ Million) Table 239. Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Application (2021-2026) & (g) Table 240. Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Application (2027-2032) & (g) Table 241. Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Price by Application (2021-2026) & (USD/g) Table 242. Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Price by Application (2027-2032) & (USD/g) Table 243. Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 244. Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 245. Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 246. Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Country (2021 VS 2025 VS 2032) & (g) Table 247. Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Country (2021-2026) & (g) Table 248. Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Country (2027-2032) & (g) Table 249. Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Price by Country (2021-2026) & (USD/g) Table 250. Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Price by Country (2027-2032) & (USD/g) Table 251. Germany Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue (2021-2032) & (US$ Million) Table 252. France Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue (2021-2032) & (US$ Million) Table 253. U.K. Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue (2021-2032) & (US$ Million) Table 254. Italy Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue (2021-2032) & (US$ Million) Table 255. Russia Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue (2021-2032) & (US$ Million) Table 256. Spain Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue (2021-2032) & (US$ Million) Table 257. Netherlands Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue (2021-2032) & (US$ Million) Table 258. Switzerland Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue (2021-2032) & (US$ Million) Table 259. Sweden Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue (2021-2032) & (US$ Million) Table 260. Poland Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue (2021-2032) & (US$ Million) Table 261. China Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Type (2021-2026) & (US$ Million) Table 262. China Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Type (2027-2032) & (US$ Million) Table 263. China Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Type (2021-2026) & (g) Table 264. China Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Type (2027-2032) & (g) Table 265. China Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Price by Type (2021-2026) & (USD/g) Table 266. China Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Price by Type (2027-2032) & (USD/g) Table 267. China Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Application (2021-2026) & (US$ Million) Table 268. China Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Application (2027-2032) & (US$ Million) Table 269. China Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Application (2021-2026) & (g) Table 270. China Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Application (2027-2032) & (g) Table 271. China Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Price by Application (2021-2026) & (USD/g) Table 272. China Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Price by Application (2027-2032) & (USD/g) Table 273. Asia Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Type (2021-2026) & (US$ Million) Table 274. Asia Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Type (2027-2032) & (US$ Million) Table 275. Asia Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Type (2021-2026) & (g) Table 276. Asia Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Type (2027-2032) & (g) Table 277. Asia Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Price by Type (2021-2026) & (USD/g) Table 278. Asia Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Price by Type (2027-2032) & (USD/g) Table 279. Asia Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Application (2021-2026) & (US$ Million) Table 280. Asia Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Application (2027-2032) & (US$ Million) Table 281. Asia Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Application (2021-2026) & (g) Table 282. Asia Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Application (2027-2032) & (g) Table 283. Asia Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Price by Application (2021-2026) & (USD/g) Table 284. Asia Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Price by Application (2027-2032) & (USD/g) Table 285. Asia Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 286. Asia Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 287. Asia Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 288. Asia Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Country (2021 VS 2025 VS 2032) & (g) Table 289. Asia Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Country (2021-2026) & (g) Table 290. Asia Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Country (2027-2032) & (g) Table 291. Asia Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Price by Country (2021-2026) & (USD/g) Table 292. Asia Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Price by Country (2027-2032) & (USD/g) Table 293. Japan Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue (2021-2032) & (US$ Million) Table 294. South Korea Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue (2021-2032) & (US$ Million) Table 295. India Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue (2021-2032) & (US$ Million) Table 296. Australia Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue (2021-2032) & (US$ Million) Table 297. Taiwan Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue (2021-2032) & (US$ Million) Table 298. Southeast Asia Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue (2021-2032) & (US$ Million) Table 299. SAMEA Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Type (2021-2026) & (US$ Million) Table 300. SAMEA Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Type (2027-2032) & (US$ Million) Table 301. SAMEA Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Type (2021-2026) & (g) Table 302. SAMEA Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Type (2027-2032) & (g) Table 303. SAMEA Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Price by Type (2021-2026) & (USD/g) Table 304. SAMEA Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Price by Type (2027-2032) & (USD/g) Table 305. SAMEA Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Application (2021-2026) & (US$ Million) Table 306. SAMEA Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Application (2027-2032) & (US$ Million) Table 307. SAMEA Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Application (2021-2026) & (g) Table 308. SAMEA Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Application (2027-2032) & (g) Table 309. SAMEA Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Price by Application (2021-2026) & (USD/g) Table 310. SAMEA Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Price by Application (2027-2032) & (USD/g) Table 311. SAMEA Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 312. SAMEA Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 313. SAMEA Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 314. SAMEA Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Country (2021 VS 2025 VS 2032) & (g) Table 315. SAMEA Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Country (2021-2026) & (g) Table 3

Scope & coverage.

Types
  • Purity: ≥98.0% (GC)
  • Purity: ＜98.0% (GC)
Applications
  • Chemical Reagent
  • Fine Chemicals
  • Pharmaceutical Intermediate
  • Material Intermediate
  • Medical
  • Scientific Research
  • Medical
  • Scientific Research
Companies covered
  • TCI America
  • City Chemical
  • Combi Blocks
  • Santa Cruz Biotechnology
  • abcr GmbH
  • BOC Sciences
  • Aceschem Inc
  • A2B Chem
  • Amadis Chemical
  • Chiralen Pharmaceutical
  • Starshine Chemical
  • Ambinter (Greenpharma)
  • AstaTech
  • Shanghai Maikelin Biochemical Technology
  • Aladdin
  • Chiron
  • Sigma-Aldrich
  • Thermo Scientific
  • Matrix Scientific
  • AbMole Bioscience
  • Smolecule
  • Biosynth
  • Alfa Chemistry
  • ChemScence
  • Fujifilm
  • Sichuan Zhongbang New Materials
  • Minxiang Pharmaceutical
  • Meryer (Shanghai) Chemical Technology
  • J&K Scientific

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market by Type
  3. 1.2.1 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Purity: ≥98.0% (GC)
  5. 1.2.3 Purity: ＜98.0% (GC)
  6. 1.3 Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market by Application
  7. 1.3.1 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Chemical Reagent
  9. 1.3.3 Fine Chemicals
  10. 1.3.4 Pharmaceutical Intermediate
  11. 1.3.5 Material Intermediate
  12. 1.3.6 Medical
  13. 1.3.7 Scientific Research
  14. 1.3.8 Medical
  15. 1.3.9 Scientific Research
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Dynamics
  1. 2.1 Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Industry Trends
  2. 2.2 Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Industry Drivers
  3. 2.3 Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Industry Opportunities and Challenges
  4. 2.4 Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Industry Restraints
3 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Production Overview
  1. 3.1 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Production Capacity (2021-2032)
  2. 3.2 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Production by Region: 2021 VS 2025 VS 2032
  3. 3.3 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Production by Region
  4. 3.3.1 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Production by Region (2021-2026)
  5. 3.3.2 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Production by Region (2027-2032)
  6. 3.3.3 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Production Market Share by Region (2021-2032)
  7. 3.4 North America
  8. 3.5 Europe
  9. 3.6 China
  10. 3.7 Japan
4 Global Market Growth Prospects
  1. 4.1 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue Estimates and Forecasts (2021-2032)
  2. 4.2 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Region
  3. 4.2.1 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Region: 2021 VS 2025 VS 2032
  4. 4.2.2 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Region (2021-2026)
  5. 4.2.3 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Region (2027-2032)
  6. 4.2.4 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue Market Share by Region (2021-2032)
  7. 4.3 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Estimates and Forecasts 2021-2032
  8. 4.4 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Region
  9. 4.4.1 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Region: 2021 VS 2025 VS 2032
  10. 4.4.2 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Region (2021-2026)
  11. 4.4.3 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Region (2027-2032)
  12. 4.4.4 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share by Region (2021-2032)
  13. 4.5 North America
  14. 4.6 Europe
  15. 4.7 China
  16. 4.8 Asia (Excluding China)
  17. 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
  1. 5.1 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Manufacturers
  2. 5.1.1 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Manufacturers (2021-2026)
  3. 5.1.2 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue Market Share by Manufacturers (2021-2026)
  4. 5.1.3 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 5.2 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Manufacturers
  6. 5.2.1 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Manufacturers (2021-2026)
  7. 5.2.2 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share by Manufacturers (2021-2026)
  8. 5.2.3 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 5.3 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Price by Manufacturers (2021-2026)
  10. 5.4 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 5.5 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Key Manufacturers Manufacturing Sites & Headquarters
  12. 5.6 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Manufacturers, Product Type & Application
  13. 5.7 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Manufacturers Commercialization Time
  14. 5.8 Market Competitive Analysis
  15. 5.8.1 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market CR5 and HHI
  16. 5.8.2 2025 Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Tier 1, Tier 2, and Tier 3
6 Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market by Type
  1. 6.1 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Type
  2. 6.1.1 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Type (2021-2032) & (US$ Million)
  3. 6.1.2 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue Market Share by Type (2021-2032)
  4. 6.2 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Type
  5. 6.2.1 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Type (2021-2032) & (g)
  6. 6.2.2 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share by Type (2021-2032)
  7. 6.3 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Price by Type
7 Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market by Application
  1. 7.1 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Application
  2. 7.1.1 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Application (2021-2032) & (US$ Million)
  3. 7.1.2 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue Market Share by Application (2021-2032)
  4. 7.2 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Application
  5. 7.2.1 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Application (2021-2032) & (g)
  6. 7.2.2 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Market Share by Application (2021-2032)
  7. 7.3 Global Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Price by Application
8 Company Profiles
  1. 8.1 TCI America
  2. 8.1.1 TCI America Company Information
  3. 8.1.2 TCI America Business Overview
  4. 8.1.3 TCI America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 8.1.4 TCI America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  6. 8.1.5 TCI America Recent Developments
  7. 8.2 City Chemical
  8. 8.2.1 City Chemical Company Information
  9. 8.2.2 City Chemical Business Overview
  10. 8.2.3 City Chemical Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 8.2.4 City Chemical Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  12. 8.2.5 City Chemical Recent Developments
  13. 8.3 Combi Blocks
  14. 8.3.1 Combi Blocks Company Information
  15. 8.3.2 Combi Blocks Business Overview
  16. 8.3.3 Combi Blocks Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 8.3.4 Combi Blocks Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  18. 8.3.5 Combi Blocks Recent Developments
  19. 8.4 Santa Cruz Biotechnology
  20. 8.4.1 Santa Cruz Biotechnology Company Information
  21. 8.4.2 Santa Cruz Biotechnology Business Overview
  22. 8.4.3 Santa Cruz Biotechnology Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 8.4.4 Santa Cruz Biotechnology Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  24. 8.4.5 Santa Cruz Biotechnology Recent Developments
  25. 8.5 abcr GmbH
  26. 8.5.1 abcr GmbH Company Information
  27. 8.5.2 abcr GmbH Business Overview
  28. 8.5.3 abcr GmbH Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 8.5.4 abcr GmbH Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  30. 8.5.5 abcr GmbH Recent Developments
  31. 8.6 BOC Sciences
  32. 8.6.1 BOC Sciences Company Information
  33. 8.6.2 BOC Sciences Business Overview
  34. 8.6.3 BOC Sciences Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 8.6.4 BOC Sciences Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  36. 8.6.5 BOC Sciences Recent Developments
  37. 8.7 Aceschem Inc
  38. 8.7.1 Aceschem Inc Company Information
  39. 8.7.2 Aceschem Inc Business Overview
  40. 8.7.3 Aceschem Inc Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 8.7.4 Aceschem Inc Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  42. 8.7.5 Aceschem Inc Recent Developments
  43. 8.8 A2B Chem
  44. 8.8.1 A2B Chem Company Information
  45. 8.8.2 A2B Chem Business Overview
  46. 8.8.3 A2B Chem Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 8.8.4 A2B Chem Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  48. 8.8.5 A2B Chem Recent Developments
  49. 8.9 Amadis Chemical
  50. 8.9.1 Amadis Chemical Company Information
  51. 8.9.2 Amadis Chemical Business Overview
  52. 8.9.3 Amadis Chemical Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 8.9.4 Amadis Chemical Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  54. 8.9.5 Amadis Chemical Recent Developments
  55. 8.10 Chiralen Pharmaceutical
  56. 8.10.1 Chiralen Pharmaceutical Company Information
  57. 8.10.2 Chiralen Pharmaceutical Business Overview
  58. 8.10.3 Chiralen Pharmaceutical Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 8.10.4 Chiralen Pharmaceutical Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  60. 8.10.5 Chiralen Pharmaceutical Recent Developments
  61. 8.11 Starshine Chemical
  62. 8.11.1 Starshine Chemical Company Information
  63. 8.11.2 Starshine Chemical Business Overview
  64. 8.11.3 Starshine Chemical Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 8.11.4 Starshine Chemical Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  66. 8.11.5 Starshine Chemical Recent Developments
  67. 8.12 Ambinter (Greenpharma)
  68. 8.12.1 Ambinter (Greenpharma) Company Information
  69. 8.12.2 Ambinter (Greenpharma) Business Overview
  70. 8.12.3 Ambinter (Greenpharma) Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 8.12.4 Ambinter (Greenpharma) Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  72. 8.12.5 Ambinter (Greenpharma) Recent Developments
  73. 8.13 AstaTech
  74. 8.13.1 AstaTech Company Information
  75. 8.13.2 AstaTech Business Overview
  76. 8.13.3 AstaTech Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 8.13.4 AstaTech Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  78. 8.13.5 AstaTech Recent Developments
  79. 8.14 Shanghai Maikelin Biochemical Technology
  80. 8.14.1 Shanghai Maikelin Biochemical Technology Company Information
  81. 8.14.2 Shanghai Maikelin Biochemical Technology Business Overview
  82. 8.14.3 Shanghai Maikelin Biochemical Technology Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 8.14.4 Shanghai Maikelin Biochemical Technology Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  84. 8.14.5 Shanghai Maikelin Biochemical Technology Recent Developments
  85. 8.15 Aladdin
  86. 8.15.1 Aladdin Company Information
  87. 8.15.2 Aladdin Business Overview
  88. 8.15.3 Aladdin Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 8.15.4 Aladdin Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  90. 8.15.5 Aladdin Recent Developments
  91. 8.16 Chiron
  92. 8.16.1 Chiron Company Information
  93. 8.16.2 Chiron Business Overview
  94. 8.16.3 Chiron Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 8.16.4 Chiron Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  96. 8.16.5 Chiron Recent Developments
  97. 8.17 Sigma-Aldrich
  98. 8.17.1 Sigma-Aldrich Company Information
  99. 8.17.2 Sigma-Aldrich Business Overview
  100. 8.17.3 Sigma-Aldrich Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 8.17.4 Sigma-Aldrich Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  102. 8.17.5 Sigma-Aldrich Recent Developments
  103. 8.18 Thermo Scientific
  104. 8.18.1 Thermo Scientific Company Information
  105. 8.18.2 Thermo Scientific Business Overview
  106. 8.18.3 Thermo Scientific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 8.18.4 Thermo Scientific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  108. 8.18.5 Thermo Scientific Recent Developments
  109. 8.19 Matrix Scientific
  110. 8.19.1 Matrix Scientific Company Information
  111. 8.19.2 Matrix Scientific Business Overview
  112. 8.19.3 Matrix Scientific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 8.19.4 Matrix Scientific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  114. 8.19.5 Matrix Scientific Recent Developments
  115. 8.20 AbMole Bioscience
  116. 8.20.1 AbMole Bioscience Company Information
  117. 8.20.2 AbMole Bioscience Business Overview
  118. 8.20.3 AbMole Bioscience Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 8.20.4 AbMole Bioscience Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  120. 8.20.5 AbMole Bioscience Recent Developments
  121. 8.21 Smolecule
  122. 8.21.1 Smolecule Company Information
  123. 8.21.2 Smolecule Business Overview
  124. 8.21.3 Smolecule Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 8.21.4 Smolecule Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  126. 8.21.5 Smolecule Recent Developments
  127. 8.22 Biosynth
  128. 8.22.1 Biosynth Company Information
  129. 8.22.2 Biosynth Business Overview
  130. 8.22.3 Biosynth Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 8.22.4 Biosynth Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  132. 8.22.5 Biosynth Recent Developments
  133. 8.23 Alfa Chemistry
  134. 8.23.1 Alfa Chemistry Company Information
  135. 8.23.2 Alfa Chemistry Business Overview
  136. 8.23.3 Alfa Chemistry Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue, Price and Gross Margin (2021-2026)
  137. 8.23.4 Alfa Chemistry Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  138. 8.23.5 Alfa Chemistry Recent Developments
  139. 8.24 ChemScence
  140. 8.24.1 ChemScence Company Information
  141. 8.24.2 ChemScence Business Overview
  142. 8.24.3 ChemScence Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue, Price and Gross Margin (2021-2026)
  143. 8.24.4 ChemScence Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  144. 8.24.5 ChemScence Recent Developments
  145. 8.25 Fujifilm
  146. 8.25.1 Fujifilm Company Information
  147. 8.25.2 Fujifilm Business Overview
  148. 8.25.3 Fujifilm Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue, Price and Gross Margin (2021-2026)
  149. 8.25.4 Fujifilm Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  150. 8.25.5 Fujifilm Recent Developments
  151. 8.26 Sichuan Zhongbang New Materials
  152. 8.26.1 Sichuan Zhongbang New Materials Company Information
  153. 8.26.2 Sichuan Zhongbang New Materials Business Overview
  154. 8.26.3 Sichuan Zhongbang New Materials Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue, Price and Gross Margin (2021-2026)
  155. 8.26.4 Sichuan Zhongbang New Materials Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  156. 8.26.5 Sichuan Zhongbang New Materials Recent Developments
  157. 8.27 Minxiang Pharmaceutical
  158. 8.27.1 Minxiang Pharmaceutical Company Information
  159. 8.27.2 Minxiang Pharmaceutical Business Overview
  160. 8.27.3 Minxiang Pharmaceutical Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue, Price and Gross Margin (2021-2026)
  161. 8.27.4 Minxiang Pharmaceutical Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  162. 8.27.5 Minxiang Pharmaceutical Recent Developments
  163. 8.28 Meryer (Shanghai) Chemical Technology
  164. 8.28.1 Meryer (Shanghai) Chemical Technology Company Information
  165. 8.28.2 Meryer (Shanghai) Chemical Technology Business Overview
  166. 8.28.3 Meryer (Shanghai) Chemical Technology Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue, Price and Gross Margin (2021-2026)
  167. 8.28.4 Meryer (Shanghai) Chemical Technology Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  168. 8.28.5 Meryer (Shanghai) Chemical Technology Recent Developments
  169. 8.29 J&K Scientific
  170. 8.29.1 J&K Scientific Company Information
  171. 8.29.2 J&K Scientific Business Overview
  172. 8.29.3 J&K Scientific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales, Revenue, Price and Gross Margin (2021-2026)
  173. 8.29.4 J&K Scientific Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Product Portfolio
  174. 8.29.5 J&K Scientific Recent Developments
9 North America
  1. 9.1 North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size by Type
  2. 9.1.1 North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Type (2021-2032)
  3. 9.1.2 North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Type (2021-2032)
  4. 9.1.3 North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Price by Type (2021-2032)
  5. 9.2 North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size by Application
  6. 9.2.1 North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Application (2021-2032)
  7. 9.2.2 North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Application (2021-2032)
  8. 9.2.3 North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Price by Application (2021-2032)
  9. 9.3 North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size by Country
  10. 9.3.1 North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 North America Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Price by Country (2021-2032)
  13. 9.3.4 United States
  14. 9.3.5 Canada
  15. 9.3.6 Mexico
10 Europe
  1. 10.1 Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size by Type
  2. 10.1.1 Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Type (2021-2032)
  3. 10.1.2 Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Type (2021-2032)
  4. 10.1.3 Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Price by Type (2021-2032)
  5. 10.2 Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size by Application
  6. 10.2.1 Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Application (2021-2032)
  7. 10.2.2 Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Application (2021-2032)
  8. 10.2.3 Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Price by Application (2021-2032)
  9. 10.3 Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size by Country
  10. 10.3.1 Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 10.3.2 Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Country (2021 VS 2025 VS 2032)
  12. 10.3.3 Europe Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Price by Country (2021-2032)
  13. 10.3.4 Germany
  14. 10.3.5 France
  15. 10.3.6 U.K.
  16. 10.3.7 Italy
  17. 10.3.8 Russia
  18. 10.3.9 Spain
  19. 10.3.10 Netherlands
  20. 10.3.11 Switzerland
  21. 10.3.12 Sweden
11 China
  1. 11.1 China Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size by Type
  2. 11.1.1 China Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Type (2021-2032)
  3. 11.1.2 China Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Type (2021-2032)
  4. 11.1.3 China Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Price by Type (2021-2032)
  5. 11.2 China Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size by Application
  6. 11.2.1 China Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Application (2021-2032)
  7. 11.2.2 China Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Application (2021-2032)
  8. 11.2.3 China Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Price by Application (2021-2032)
12 Asia (Excluding China)
  1. 12.1 Asia Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size by Type
  2. 12.1.1 Asia Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Type (2021-2032)
  3. 12.1.2 Asia Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Type (2021-2032)
  4. 12.1.3 Asia Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Price by Type (2021-2032)
  5. 12.2 Asia Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size by Application
  6. 12.2.1 Asia Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Application (2021-2032)
  7. 12.2.2 Asia Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Application (2021-2032)
  8. 12.2.3 Asia Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Price by Application (2021-2032)
  9. 12.3 Asia Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size by Country
  10. 12.3.1 Asia Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 Asia Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 Asia Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Price by Country (2021-2032)
  13. 12.3.4 Japan
  14. 12.3.5 South Korea
  15. 12.3.6 India
  16. 12.3.7 Australia
  17. 12.3.8 Taiwan
  18. 12.3.9 Southeast Asia
13 South America, Middle East and Africa
  1. 13.1 SAMEA Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size by Type
  2. 13.1.1 SAMEA Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Type (2021-2032)
  3. 13.1.2 SAMEA Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Type (2021-2032)
  4. 13.1.3 SAMEA Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Price by Type (2021-2032)
  5. 13.2 SAMEA Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size by Application
  6. 13.2.1 SAMEA Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue by Application (2021-2032)
  7. 13.2.2 SAMEA Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Application (2021-2032)
  8. 13.2.3 SAMEA Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Price by Application (2021-2032)
  9. 13.3 SAMEA Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Market Size by Country
  10. 13.3.1 SAMEA Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 13.3.2 SAMEA Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales by Country (2021 VS 2025 VS 2032)
  12. 13.3.3 SAMEA Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Price by Country (2021-2032)
  13. 13.3.4 Brazil
  14. 13.3.5 Argentina
  15. 13.3.6 Chile
  16. 13.3.7 Colombia
  17. 13.3.8 Peru
  18. 13.3.9 Saudi Arabia
  19. 13.3.10 Israel
  20. 13.3.11 UAE
  21. 13.3.12 Turkey
  22. 13.3.13 Iran
  23. 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
  1. 14.1 Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Value Chain Analysis
  2. 14.1.1 Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Key Raw Materials
  3. 14.1.2 Raw Materials Key Suppliers
  4. 14.1.3 Manufacturing Cost Structure
  5. 14.1.4 Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Production Mode & Process
  6. 14.2 Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Sales Channels Analysis
  7. 14.2.1 Direct Comparison with Distribution Share
  8. 14.2.2 Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Distributors
  9. 14.2.3 Diamantane (CAS 2292-79-7) and Adamantane (CAS 281-23-2) Customers
15 Concluding Insights
    16 Appendix
    1. 16.1 Reasons for Doing This Study
    2. 16.2 Research Methodology
    3. 16.3 Research Process
    4. 16.4 Authors List of This Report
    5. 16.5 Data Source
    6. 16.5.1 Secondary Sources
    7. 16.5.2 Primary Sources
    8. 16.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst